Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company EntreChem S.L.
DescriptionInhibitor of VEGF and v-myc myelocytomatosis viral oncogene homolog (MYC; c-Myc) through the modulation of Sp1 transcription factor (SP1)
Molecular Target Sp1 transcription factor (SP1)
Mechanism of Actionc-myc inhibitor; Vascular endothelial growth factor (VEGF) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today